Subsequent studies will assess HLA-DR\DP\DQ co-expression with Tregs and MDSCs via single-cell RNA sequencing or immunofluorescence and evaluate combining immune checkpoint inhibitors (e.g., anti-PD-1/PD-L1) in ESCC immunotherapy. Here, CD274 is linked to esophageal squamous cell carcinoma.